PHARMACY

FDA approves new strength of HIV drug

BY Alaric DeArment

TITUSVILLE, N.J. — The Food and Drug Administration has approved a new strength of a drug for HIV made by Johnson & Johnson, the drug maker said.

J&J subsidiary Janssen Therapeutics announced the approval of an 800-mg formulation of Prezista (darunavir) as a once-daily treatment for HIV. The drug is designed to be taken with food at the same time as ritonavir and in combination with other HIV drugs.

"The single 800-mg tablet provides an option for a reduced pill burden and reflects our ongoing commitment to offer more treatment options for the diverse population of people living with HIV," Janssen Therapeutics medical director Bryan Baugh said.


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

FDA approves Watson PAH drug

BY Alaric DeArment

PARSIPPANY, N.J. — The Food and Drug Administration has approved a generic drug for pulmonary arterial hypertension made by Watson Pharmaceuticals, the drug maker said Monday.

Watson said the FDA approved its sildenafil tablets in the 20 mg strength through a subsidiary. Watson said it would launch the drug "in the near future."

The drug is a generic version of Pfizer’s Revatio tablets, which had sales of about $339 million during the 12-month period ended in September, according to IMS Health.


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

Cardinal arms community pharmacists with resources to augment diabetes awareness efforts

BY Michael Johnsen

DUBLIN, Ohio — Cardinal Health on Monday announced the availability of free, downloadable materials to help community pharmacists educate patients about effective strategies for preventing and living with diabetes as part of National Diabetes Awareness Month. 

“The diabetes population is expected to double by 2034, and we are committed to providing community pharmacists with the tools and resources they need to help these patients better understand and manage this disease," stated Christi Pedra, SVP marketing for Cardinal Health’s Pharmaceutical segment. 

Cardinal Health is providing access to the following tools and materials:

  • An interactive presentation, developed in partnership with CreativePharmacist.com, which helps pharmacists educate patients about diabetes awareness, risk prevention and daily management. The presentation also focuses on how patients can build their relationships with their local pharmacist to improve healthcare outcomes;
  • Patient informational handouts that help the patient follow along with the interactive presentation, allowing the patient to record what they are learning about diabetes from their pharmacist;
  • An ADA risk assessment form that helps patients identify whether they are at risk of developing the disease; and
  • Promotional materials, including customizable bag clippers and flyers.

Cardinal Health also offers a Specialized Care Center focused on diabetes where participating pharmacies have access to an array of tools and resources to help position themselves as a local destination for diabetes care.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?